Can a simple blood test catch Alzheimer's before symptoms start?

NCT ID NCT06121544

Recruiting now Knowledge-focused Sponsor: Skane University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking for early warning signs of Alzheimer's disease in 800 cognitively healthy adults aged 50 to 80. Researchers will use blood tests, brain scans, and memory assessments over about 4 years to see how Alzheimer's-related changes develop. The goal is to find a way to screen the general population for Alzheimer's risk long before memory loss begins.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help develop a screening tool to detect Alzheimer's years before symptoms appear, enabling earlier intervention.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly benefit participants. Results may not lead to a practical screening test for the general population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE MILD COGNITIVE IMPAIRMENT MILD DEMENTIA

Contacts and locations

Locations

Skåne University Hospital
RECRUITING

Malmö, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.